Finding that activated T cells control osteoclast (OCL) differentiation has revealed the importance of the interactions between immune and bone cells. Dendritic cells (DCs) are responsible for T cell activation and share common precursors with OCLs. Here, we show that DCs participate in bone resorption more directly than simply through T cell activation.
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ABSTRACT
Finding that activated T cells control osteoclast (OCL) differentiation has revealed the importance of the interactions between immune and bone cells. Dendritic cells (DCs) are responsible for T cell activation and share common precursors with OCLs. Here, we show that DCs participate in bone resorption more directly than simply through T cell activation.
We show that among the splenic DC subsets, the conventional DCs (cDCs) have the higher osteoclastogenic potential in vitro. We demonstrate that cDCs differentiate into functional For personal use only. on March 31, 2017 . by guest www.bloodjournal.org From
INTRODUCTION
An increasing number of studies underline the interactions between the bone and immune systems, and have led to the emergence of osteoimmunology 1, 2 . Excessive bone resorption is frequently associated with chronic infections, autoimmune, and inflammatory diseases [3] [4] [5] [6] . The immune system plays a major role in this process, in particular through activated T cells which secrete proinflammatory cytokines involved in osteoclastogenesis 7 .
However, less is known about the involvement of other immune cells in the control of bone resorption. Dendritic cells (DCs) also play an important role in autoimmune and inflammatory diseases 8 . These cells derive from the same myeloid precursor than osteoclasts (OCLs) and both cell types are modulated by common factors, mainly by receptor activator of NF-κB ligand (RANK-L). RANK-L is essential for the differentiation of OCLs 9 , the activity and survival of DCs 10 . These data highlight a potential link between DCs and OCLs.
Cells from the myelomonocytic lineage, including DCs, display a high developmental and functional plasticity depending on local factors and stimuli experienced during their differentiation and maturation 11, 12 . Although they were considered to be terminally differentiated cells, recent studies have suggested that mature splenic DCs can be influenced by their microenvironment to undergo further differentiation. Splenic stromal cells induce mature DCs to differentiate into regulatory DCs which differ from mature DCs by their phenotype, their cytokine secretion pattern and their ability to inhibit T cell proliferation 13 .
Moreover, DCs generated in vitro transdifferentiate into endothelial cells when cultured with tumor-conditioned media 14 or into OCLs when cultured with osteoclastogenic factors 15, 16 .
Although these in vitro studies revealed the capacity of DCs to transdifferentiate into other cell types under specific conditions, it is not clear yet whether this plasticity takes place in vivo.
Osteopetrosis is characterized by an impaired bone resorption due to the absence of OCL formation or activity 17 . In the osteopetrotic oc/oc mouse, differentiated OCLs are present but are unable to resorb bone due to a deletion in the Tcirg1 gene encoding the a3 subunit of the vacuolar ATPase 18 . The a3 protein is responsible for the acidification process
For personal use only. on March 31, 2017 . by guest www.bloodjournal.org From 4 necessary for the dissolution of the bone matrix leading to the formation of resorption lacunae. In the absence of a3 expression, the bone marrow of oc/oc mice is filled with numerous and disorganized trabeculae, and osteoclastogenesis is highly increased 19, 20 . The consequence of this severe osteopetrotic phenotype is a life span under 3 weeks. Therefore, the oc/oc mouse provides an appropriate model to assess the in vivo capacity of wild type precursor cells to give rise to functional OCLs.
To assess whether DCs have an osteoclastogenic potential, we purified them from normal mice and cultured them with RANK-L and macrophage-colony stimulating factor (M-CSF). We showed that this treatment allows DCs to differentiate efficiently into fully functional OCLs. However, each of the DC subsets had a different osteoclastogenic capacity, the most efficient beeing the conventional CD11c high MHC-II + DCs (cDCs). We have therefore characterized in more details the differentiation of cDCs into OCLs in vitro. This process was accompanied by an up-regulation of Nfatc1, a transcription factor essential for osteoclastogenesis, as shown for classical OCLs precursors. We also evaluated this differentiation potential in vivo using the osteopetrotic oc/oc mouse deficient in OCL activity.
We showed that splenic cDCs isolated from normal mice are able to home into the bone marrow and partially reverse the osteopetrotic phenotype of oc/oc mice by differentiating into functional OCLs. This differentiation is highly favoured in oc/oc mice bone marrow due to the presence of inflammatory CD4 + T cells able to maintain a high RANK-L expression by bone marrow stromal cells.
This report is the first demonstration that, in vivo, cDCs can be influenced by the bone marrow cellular environment to participate to bone resorption through their differentiation into OCLs, and can be efficient in the treatment of a bone resorption disease.
For personal use only. on March 31, 2017 . by guest www.bloodjournal.org From
5
MATERIALS AND METHODS
Mice and treatment
Oc/oc mice were genotyped as described 20 , 1 day after birth. CD11c-DTR/GFP mice 21 were obtained from CDTA (Orléans, France). Animals were maintained in our animal facility in accordance with the general guidelines of the Direction des Services Vétérinaires. When indicated, oc/oc and control mice received total body irradiation of 3 Gy (non lethal dose) one day after birth. On day 2 after birth, mice received intraperitoneal (IP) injection of either 50μl PBS (control oc/oc mice), or 2 to 15.10 6 splenic DCs purified from naive +/+ mice in 50μl
PBS. Animals injected with DCs from CD11c-DTR/GFP were irradiated and received an injection of 5.10 6 DCs together with diphteria toxin (4 ng/g body weight). Animals were sacrificed at the indicated day. Approval for the use of mice in this study was obtained from the animal facility committee from the faculty of Medicine at the University of Nice Sophia Antipolis.
Purification of conventional splenic DCs and monocytes
cDCs were sorted from spleens of 5-week-old naive +/+ mice. After red blood cell lysis, splenocytes were depleted for T, B, NK cells, monocytes and granulocytes, by treatment with monoclonal antibody mixture containing anti-CD3 (17A2), anti-CD19 (1D3), anti-CD49b (DX5), and anti-Ly6G/6C (RB6-8C5) (Pharmingen) and separation with anti-rat Ig-coated magnetic beads (Dynal). cDCs were obtained after CD11c + enrichment of the remaining splenocytes by positive selection with CD11c microbeads on LS columns (Miltenyi-Biotech).
Enriched cells were labelled with APC-CD11c (HL3) and FITC-IAb (AF6-120.1), and the 
RESULTS
Splenic cDCs differentiate into functional OCLs in vitro
In vitro generated DCs have been shown to form OCLs in the presence of RANK-L and M-CSF 15, 16 . However, the contribution of the different natural DC subsets has not been analyzed. Therefore, we analyzed the osteoclastogenic potential of the various splenic DC subsets. Our results show that cDCs differentiate into OCLs more efficiently than pDCs and that among the cDC subsets, the CD4 -CD8 -subset contributes much more efficiently than others to this differentiation ( Figure S1 ). Thus, we have further evaluated the formation of
OCLs from cDCs purified from mouse spleen using CD11c, a specific cell surface marker of this population. , with more than 80% beeing multinucleated. In resorption assays, the surface of resorption pits corresponded to 40-50% of dentine slice surface ( Figure 2C and data not shown).
Differentiation of cDCs into OCLs is RANK-L and M-CSF dependent
Lineage bifurcation between DCs and OCLs from a common progenitor is reciprocally regulated by GM-CSF and M-CSF 28 . We therefore examined the effect of these cytokines on the DC-to-OCL differentiation. This differentiation requires the presence of both RANK-L and M-CSF ( Figure 2D ), and is inhibited by addition of GM-CSF ( Figure 2D ).
The negative effect of GM-CSF on differentiation OCLs from monocytes is, in part, mediated by a down regulation of NFATc1, a RANK-L-induced factor essential for osteoclastogenesis 29, 30 . NFATc1 NFATc1 is essential for osteoclastogenesis, this inhibition could explain the suppression by GM-CSF of DCs-to-OCL differentiation, as reported for OCL differentiation from monocytes 29 . In summary, our results show that splenic cDCs do behave as monocytic OCL precursors and that cDCs and monocytes probably share common signaling pathways.
Bone resorption activity is restored in cDC-treated oc/oc mice
These observations prompted us to examine whether splenic cDCs can generate OCLs in vivo. We have used the osteopetrotic oc/oc mouse as a model for detecting activity of OCLs derived from cDCs. These mice die before the age of 3 weeks due to their severe osteopetrotic phenotype. Their bone marrow is filled with numerous and disorganized trabeculae, and osteoclastogenesis is increased but leads to non functional OCLs 19, 20 .
For personal use only. on March 31, 2017 . by guest www.bloodjournal.org From Furthermore, they display a high expression of Rank-l and M-csf in the bone marrow compared to normal littermates ( Figure S2 ). Thus, oc/oc mice are able to generate a high number of OCLs and provide an appropriate microenvironment to assess the in vivo capacity of DCs to give rise to OCLs. Two-day-old oc/oc mice were injected with FACS-purified cDCs from +/+ mice. Three independent experiments were performed using different numbers of DCs in irradiated or non-irradiated mice. In all experiments, the life span of DC-treated oc/oc mice increased at least 2-3 folds compared to PBS-treated oc/oc mice ( Figure 3A) , indicating an improvement of their phenotype. Radiological analysis of DC-treated oc/oc mice that survived over one month of age (n=6) revealed the presence of a partial marrow cavity in long bones ( Figure   3B ) whatever the experimental conditions, whereas such a cavity was never observed in control oc/oc mice, indicating that a bone resorption activity has been restored in DC-treated mice. The cavity size was variable, the larger ones being observed in irradiated mice treated with 5.10 6 DCs ( Figure 3B , mice 5-6). In all experiments, no change in radiological analysis was observed in DC-treated oc/oc mice that died before one month of age (n=8) compared to PBS-treated oc/oc mice (not shown), even if their life span was increased. Thus, no histological analysis of their bone phenotype was performed. This result is consistant with the observation that in oc/oc mice transplanted with hematopoietic stem cells, the first changes in bone structure observed radiographically were detected only one month after transplantation 31 . No difference in survival and phenotype was observed between untreated oc/oc mice and oc/oc mice that have been irradiated and injected with PBS (data not shown),
indicating that all these effects can not be attributed to irradiation alone. Together, these data indicate that bone phenotype is restored in about 45% of DC-treated animals, the 55% remaining animals dying before any change in bone morphology can be observed. This efficiency is close to the one observed in therapeutic assays using various hematopoietic populations in newborn oc/oc mice [31] [32] [33] . It can be explained by the fact that during the first weeks after treatment, mice remain subjected to many deleterious factors such as hematological defects, access to the mother for food, or nerve compression, that contribute to shorten their life span. Experiments were performed using 5.10 6 purified DCs injected into irradiated oc/oc mice, since these conditions gave the best bone phenotype recovery and mice survival. Injection of DT (4 ng/g body weight) in newborn mice was not lethal (not shown). In oc/oc mice injected with DCs purified from CD11c-DTR/GFP mice, administration of DT leaded to a complete depletion of injected DCs 48h after DT treatment (not shown). These mice (n=4) displayed the same life span ( Figure 3A ) and the same bone phenotype ( Figure 3B ) as control oc/oc mice, revealing an absence of rescue of the osteopetrotic phenotype. These data confirmed that CD11c + DCs are reponsible for the restoration of bone resorption in oc/oc mice and excluded the contribution of CD11c -contaminants in this effect.
To confirm the partial restoration of bone phenotype in DC-treated oc/oc mice, histological analysis were performed on tibia of mice that have survived over one month (n=6) and on control mice. In PBS-treated oc/oc mice, the growth plate was disorganized and large zones of unmineralized type-I collagen matrix were observed below this plate ( Figure   3C ), as previously described 19, 34 . In DC-treated oc/oc mice, the growth plate was normal and a partial marrow cavity variable in size was observed ( Figure 3C ).
Bone histomorphometric analysis revealed that in oc/oc mice, the bone tissue contained a mix of mineralized and unmineralized type-I collagen and cartilage, making difficult to clearly define the bone volume. Therefore, we mesured the ratio between the Figure 3D ). Fifty percent of these mice (group 1, mice 1-3) displayed a very small marrow cavity, and their MdV/TV ratio, number of nodes (reflecting the connectivity between trabeculae) and trabeculae thickness were dramatically increased compared to control oc/oc mice ( Figure 3D-E) , indicating that the bone matrix containing type-I collagen has been mineralized.
Bone resorption and formation are tightly coupled through the activity of factors released from the bone matrix during bone resorption 35 . This probably explains why the first consequence of a restoration of bone resorption in oc/oc mice is an increase in bone mineralization. Thus, our data reflect a partial restoration of the remodeling process through some resorption activity. In the 50% remaining DC-treated mice (group 2, mice 4-6) displaying the larger bone marrow cavity, morphometric parameters were not significantly different from those of +/+ mice ( Figure 3D-E) , confirming a spectacular recovery of the bone morphology and a restoration of bone resorption activity.
Such a heterogeneity in the bone phenotype was also reported in oc/oc mice treated with in utero or neonatal hematopoietic stem cell transplantation 32, 33 . In addition to the radiation dose and the number of transplanted cells, this effect was attributed to interindividual variations and to the difficulty of intraperitoneal injection in newborn mice 33 .
Altogether, our data indicate that injection of cDCs allowed partial reversion of the osteopetrotic phenotype in oc/oc mice.
Splenic cDCs differentiate into functional OCLs in vivo
To assess if injected cDCs directly contributed to the bone resorption activity, we Furthermore, bone marrow cells from DC-treated oc/oc mice cultured onto dentin slices with RANK-L and M-CSF are able to form a small number of resorption lacunae, whereas resorption pits were never observed with bone marrow cells derived from control oc/oc mice ( Figure 4D ). These data demonstrate that functional OCLs are recovered from DC-treated oc/oc mice.
Altogether, these results clearly show that active OCLs are present in oc/oc DCtreated mice and have differentiated from the injected cDCs, demonstrating that cDCs are able to differentiate into functional OCLs in vivo. Figure 5D ). These data suggest that, in the bone marrow of oc/oc mice, the main source of RANK-L is produced by stromal cells and controlled by CD4 + T cells.
CD4 + T cells contribute to the DC differentiation into OCLs in vivo
Inflammatory CD4 + T cells support the DC-to-OCL differentiation through the stimulation of marrow stromal cells
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